SCHEMBL15567221

SCHEMBL15567221

O=C(C1CC(=O)N(c2ccccc2)C1)N1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HRH1 P35367 14/20 0.54
▸ CYP2D6 P10635 13/20 0.54
▸ HTR3A P46098 1/20 0.52
▸ KCNH2 Q12809 7/20 0.52
▸ CHRM1 P11229 4/20 0.52
▸ TSHR P16473 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ PKM P14618 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ NPC1 O15118 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15567940 0.85 HRH1 (0.53) HRH1CYP2D6HTR3AKCNH2CHRM1
SCHEMBL15567862 0.84 HRH1 (0.55) HRH1CYP2D6HTR3AKCNH2CHRM1
SCHEMBL18292404 0.80 HRH1 (0.65) HRH1CYP2D6HTR3AKCNH2CHRM1
SCHEMBL15568131 0.80 HRH1 (0.61) HRH1CYP2D6HTR3AKCNH2CHRM1
SCHEMBL15569117 0.78 MEN1 (0.48) HRH1CYP2D6CHRM1MAPTTP53
SCHEMBL15568031 0.77 HTR3A (0.66) HRH1CYP2D6HTR3AKCNH2CHRM1
Trifluoroacetic Acid SCHEMBL15567810 0.77 HRH1 (0.57) HRH1CYP2D6HTR3AKCNH2CHRM1
SCHEMBL27317913 0.77 HRH1 (0.69) HRH1CYP2D6HTR3AKCNH2CHRM1
SCHEMBL15568462 0.76 CYP1A2 (0.75) HRH1CYP2D6HTR3AKCNH2CHRM1
Trifluoroacetic Acid SCHEMBL15568651 0.74 HRH1 (0.55) HRH1CYP2D6HTR3AKCNH2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 — — WO claimed
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 — — WO disclosed
Send feedback